Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1-Reference-Cited by-同舟云学术

Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1

Published:2024-07-04 Issue:8 Volume:13 Page:1877-1891
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Chandasana Hardik^ORCID,van Dijkman Sven C.,Mehta Rashmi,Bush Mark,Rabie Helena,Flynn Patricia,Cressey Tim R.,Acosta Edward P.,Brooks Kristina M.,

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-024-01008-y.pdf

Reference26 articles.

1. UNICEF data., Paediatric care and treatment; 2023. https://data.unicef.org/topic/hivaids/paediatric-treatment-and-care/. Accessed 22 Aug 2023.

2. UNICEF data. Global and regional trends; 2023. https://data.unicef.org/topic/hivaids/global-regional-trends/. Accessed 22 Aug 2023.

3. HIV treatment guidelines for the use of antiretroviral agents in pediatric HIV infection; 2023. https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/whats-new. Accessed 31 Aug 2023.

4. Guidelines for the use of antiretroviral agents in pediatric HIV infection; 2023. https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/regimens-recommended-initial-therapy-antiretroviral-naive-children. Accessed 31 Aug 2023.

5. Ramjan R, Calmy A, Vitoria M, Mills EJ, Hill A, Cooke G, et al. Systematic review and meta-analysis: patient and programme impact of fixed-dose combination antiretroviral therapy. Trop Med Int Health. 2014;19(5):501–13.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Model‐Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed‐Dose Combination Approval in Children Living with HIV‐1;The Journal of Clinical Pharmacology;2024-09-05